Tyra Announces $400M Pricing of Common Stock and Pre-Funded Warrants
Tyra priced an underwritten offering expected to raise approximately $400.0 million from sales of common stock and pre-funded warrants.Key Highlights:Original SEC Filing: Tyra Biosciences, Inc. [ TYRA ] - 8-K - Sep. 14, 2026This is an AI-powered summary. It may contain inaccuracies. Consider verify…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.